{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T15:40:50Z","timestamp":1785253250430,"version":"3.55.0"},"reference-count":90,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,1,7]],"date-time":"2025-01-07T00:00:00Z","timestamp":1736208000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,7]],"date-time":"2025-01-07T00:00:00Z","timestamp":1736208000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Neurol"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1038\/s41582-024-01047-6","type":"journal-article","created":{"date-parts":[[2025,1,7]],"date-time":"2025-01-07T16:50:48Z","timestamp":1736268648000},"page":"159-170","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Inclusion in neurological research: empowering people living with neurological diseases"],"prefix":"10.1038","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0459-9615","authenticated-orcid":false,"given":"Maria Teresa","family":"Ferretti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-8188-8310","authenticated-orcid":false,"given":"Maria Bonaria","family":"Uccheddu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richelle","family":"Flanagan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1822-3643","authenticated-orcid":false,"given":"Iracema","family":"Leroi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7968-5908","authenticated-orcid":false,"given":"Elena","family":"Moro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,7]]},"reference":[{"key":"1047_CR1","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1007\/s43441-022-00432-x","volume":"56","author":"K Schroeder","year":"2022","unstructured":"Schroeder, K. et al. Building from patient experiences to deliver patient-focused healthcare systems in collaboration with patients: a call to action. Ther. Innov. Regul. Sci. 56, 848\u2013858 (2022).","journal-title":"Ther. Innov. Regul. Sci."},{"key":"1047_CR2","unstructured":"World Health Organization. Health 2020: A European Policy Framework and Strategy for the 21st Century (WHO, 2013)."},{"key":"1047_CR3","doi-asserted-by":"publisher","first-page":"103484","DOI":"10.1016\/j.ebiom.2021.103484","volume":"70","author":"G Fox","year":"2021","unstructured":"Fox, G. et al. Patient engagement in preclinical laboratory research: a scoping review. eBioMedicine 70, 103484 (2021).","journal-title":"eBioMedicine"},{"key":"1047_CR4","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1177\/2168479017706405","volume":"51","author":"J Geissler","year":"2017","unstructured":"Geissler, J., Ryll, B., di Priolo, S. L. & Uhlenhopp, M. Improving patient involvement in medicines research and development: a practical roadmap. Ther. Innov. Regul. Sci. 51, 612\u2013619 (2017).","journal-title":"Ther. Innov. Regul. Sci."},{"key":"1047_CR5","unstructured":"National Institute for Health and Care Research. Briefing notes for researchers - public involvement in NHS, health and social care research. https:\/\/www.nihr.ac.uk\/documents\/briefing-notes-for-researchers-public-involvement-in-nhs-health-and-social-care-research\/27371 (2024)."},{"key":"1047_CR6","doi-asserted-by":"publisher","DOI":"10.1177\/23743735221125439","author":"S Marzban","year":"2022","unstructured":"Marzban, S., Najafi, M., Agolli, A. & Ashrafi, E. Impact of patient engagement on healthcare quality: a scoping review. J. Patient Exp. https:\/\/doi.org\/10.1177\/23743735221125439 (2022).","journal-title":"J. Patient Exp."},{"key":"1047_CR7","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1111\/hex.12888","volume":"22","author":"T Greenhalgh","year":"2019","unstructured":"Greenhalgh, T. et al. Frameworks for supporting patient and public involvement in research: systematic review and co\u2010design pilot. Health Expect. 22, 785\u2013801 (2019).","journal-title":"Health Expect."},{"key":"1047_CR8","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1080\/01944366908977225","volume":"35","author":"SR Arnstein","year":"1969","unstructured":"Arnstein, S. R. A ladder of citizen participation. J. Am. Inst. Plann. 35, 216\u2013224 (1969).","journal-title":"J. Am. Inst. Plann."},{"key":"1047_CR9","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1177\/1742395312466903","volume":"9","author":"C Timmermann","year":"2013","unstructured":"Timmermann, C. \u2018Just give me the best quality of life questionnaire\u2019: the Karnofsky scale and the history of quality of life measurements in cancer trials. Chronic Illn. 9, 179\u2013190 (2013).","journal-title":"Chronic Illn."},{"key":"1047_CR10","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1056\/NEJM199201093260209","volume":"326","author":"RM Wachter","year":"1992","unstructured":"Wachter, R. M. AIDS, activism, and the politics of health. N. Engl. J. Med. 326, 128\u2013133 (1992).","journal-title":"N. Engl. J. Med."},{"key":"1047_CR11","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1080\/17441692.2014.881519","volume":"9","author":"CJ Colvin","year":"2014","unstructured":"Colvin, C. J. Evidence and AIDS activism: HIV scale-up and the contemporary politics of knowledge in global public health. Glob. Public. Health 9, 57\u201372 (2014).","journal-title":"Glob. Public. Health"},{"key":"1047_CR12","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1089\/jwh.2011.2862","volume":"21","author":"JR Osuch","year":"2012","unstructured":"Osuch, J. R. et al. A historical perspective on breast cancer activism in the United States: from education and support to partnership in scientific research. J. Women\u2019s Health 21, 355\u2013362 (2012).","journal-title":"J. Women\u2019s Health"},{"key":"1047_CR13","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/j.socscimed.2005.06.023","volume":"62","author":"K Landzelius","year":"2006","unstructured":"Landzelius, K. Introduction: patient organization movements and new metamorphoses in patienthood. Soc. Sci. Med. 62, 529\u2013537 (2006).","journal-title":"Soc. Sci. Med."},{"key":"1047_CR14","doi-asserted-by":"publisher","DOI":"10.1186\/1472-6963-14-89","volume":"14","author":"JP Domecq","year":"2014","unstructured":"Domecq, J. P. et al. Patient engagement in research: a systematic review. BMC Health Serv. Res. 14, 89 (2014).","journal-title":"BMC Health Serv. Res."},{"key":"1047_CR15","first-page":"6839","volume":"12","author":"K Woudstra","year":"2023","unstructured":"Woudstra, K., Reuzel, R., Rovers, M. & Tummers, M. An overview of stakeholders, methods, topics, and challenges in participatory approaches used in the development of medical devices: a scoping review. Int. J. Health Policy Manag. 12, 6839 (2023).","journal-title":"Int. J. Health Policy Manag."},{"key":"1047_CR16","unstructured":"Wellcome Trust. Community Engagement \u2014 Under the Microscope (Wellcome Trust, 2011)."},{"key":"1047_CR17","unstructured":"World Health Organization. Intersectoral Global Action Plan on Epilepsy and Other Neurological Disorders (WHO, 2023)."},{"key":"1047_CR18","doi-asserted-by":"crossref","unstructured":"Grisold, W., Struhal, W. & Grisold, T. in Advocacy in Neurology (Oxford University Press, 2019).","DOI":"10.1093\/med\/9780198796039.001.0001"},{"key":"1047_CR19","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1001\/jama.1994.03510370075036","volume":"271","author":"MA Winker","year":"1994","unstructured":"Winker, M. A. Tacrine for Alzheimer\u2019s disease. Which patient, what dose? JAMA 271, 1023\u20131024 (1994).","journal-title":"JAMA"},{"key":"1047_CR20","first-page":"1078","volume":"23","author":"TJ Mattingly","year":"2017","unstructured":"Mattingly, T. J. & Simoni-Wastila, L. Patient-centered drug approval: the role of patient advocacy in the drug approval process. J. Manag. Care Spec. Pharm. 23, 1078\u20131082 (2017).","journal-title":"J. Manag. Care Spec. Pharm."},{"key":"1047_CR21","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-020-02427-4","volume":"18","author":"V Mahant","year":"2020","unstructured":"Mahant, V. \u201cRight-to-Try\u201d experimental drugs: an overview. J. Transl. Med. 18, 253 (2020).","journal-title":"J. Transl. Med."},{"key":"1047_CR22","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1007\/s13311-022-01271-2","volume":"19","author":"CN Fournier","year":"2022","unstructured":"Fournier, C. N. Considerations for amyotrophic lateral sclerosis (ALS) clinical trial design. Neurotherapeutics 19, 1180\u20131192 (2022).","journal-title":"Neurotherapeutics"},{"key":"1047_CR23","unstructured":"Schnell, J. et al. ALS Association Ice Bucket Challenge Impact (RTI International, 2024)."},{"key":"1047_CR24","unstructured":"European Federation of Neurological Associations. Optimising Patient Involvement in Neuroscience Research (EFNA, 2020)."},{"key":"1047_CR25","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1186\/s12877-019-1217-9","volume":"19","author":"J Miah","year":"2019","unstructured":"Miah, J. et al. Patient and public involvement in dementia research in the European Union: a scoping review. BMC Geriatr. 19, 220 (2019).","journal-title":"BMC Geriatr."},{"key":"1047_CR26","unstructured":"Alzheimer\u2019s Research UK. Other Ways to Get Involved. https:\/\/www.alzheimersresearchuk.org\/research\/getting-involved-in-research\/other-ways-to-get-involved\/ (2023)."},{"key":"1047_CR27","unstructured":"Multiple Sclerosis Society. MS Society Research Strategy 2018\u201322 (MS Society, 2022)."},{"key":"1047_CR28","doi-asserted-by":"publisher","first-page":"11","DOI":"10.12688\/hrbopenres.13205.1","volume":"4","author":"R Joyce","year":"2021","unstructured":"Joyce, R., Dwyer, C. P. & Hynes, S. M. Twelve months into a feasibility trial: reflections on three experiences of public and patient involvement in research. HRB Open. Res. 4, 11 (2021).","journal-title":"HRB Open. Res."},{"key":"1047_CR29","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s41927-023-00327-w","volume":"7","author":"A Arumugam","year":"2023","unstructured":"Arumugam, A. et al. Patient and public involvement in research: a review of practical resources for young investigators. BMC Rheumatol. 7, 2 (2023).","journal-title":"BMC Rheumatol."},{"key":"1047_CR30","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1080\/21678421.2024.2328599","volume":"25","author":"SK Genuis","year":"2024","unstructured":"Genuis, S. K. et al. Patient engagement in research: lessons learned from CAPTURE ALS, a longitudinal observational ALS study. Amyotroph. Lateral Scler. Front. Degener. 25, 634\u2013643 (2024).","journal-title":"Amyotroph. Lateral Scler. Front. Degener."},{"key":"1047_CR31","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1080\/21678421.2020.1804939","volume":"22","author":"JD Berry","year":"2021","unstructured":"Berry, J. D., Bedlack, R., Mathews, D., Agnese, W. & Apple, S. Engaging ALS patients and caregivers (the ALS research ambassadors) to help design the REFINE-ALS biomarker study. Amyotroph. Lateral Scler. Front. Degener. 22, 147\u2013150 (2021).","journal-title":"Amyotroph. Lateral Scler. Front. Degener."},{"key":"1047_CR32","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1177\/2168479017716715","volume":"52","author":"B Levitan","year":"2018","unstructured":"Levitan, B. et al. Assessing the financial value of patient engagement: a quantitative approach from CTTI\u2019s Patient Groups and Clinical Trials project. Ther. Innov. Regul. Sci. 52, 220\u2013229 (2018).","journal-title":"Ther. Innov. Regul. Sci."},{"key":"1047_CR33","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1161\/STROKEAHA.117.018912","volume":"49","author":"M Reeves","year":"2018","unstructured":"Reeves, M. et al. Patient-reported outcome measures (PROMs) for acute stroke: rationale, methods and future directions. Stroke 49, 1549\u20131556 (2018).","journal-title":"Stroke"},{"key":"1047_CR34","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-021-01366-9","volume":"22","author":"A Alpuente","year":"2021","unstructured":"Alpuente, A., Gallardo, V. J., Caronna, E., Torres-Ferrus, M. & Pozo-Rosich, P. In search of a gold standard patient-reported outcome measure to use in the evaluation and treatment-decision making in migraine prevention. A real-world evidence study. J. Headache Pain. 22, 151 (2021).","journal-title":"J. Headache Pain."},{"key":"1047_CR35","first-page":"3097","volume":"37","author":"J Panthagani","year":"2023","unstructured":"Panthagani, J. et al. Evaluating patient-reported outcome measures (PROMs) for future clinical trials in adult patients with optic neuritis. Eye Lond. Engl. 37, 3097\u20133107 (2023).","journal-title":"Eye Lond. Engl."},{"key":"1047_CR36","doi-asserted-by":"publisher","first-page":"103757","DOI":"10.1016\/j.msard.2022.103757","volume":"61","author":"P Zaratin","year":"2022","unstructured":"Zaratin, P. et al. The agenda of the global patient reported outcomes for multiple sclerosis (PROMS) initiative: progresses and open questions. Mult. Scler. Relat. Disord. 61, 103757 (2022).","journal-title":"Mult. Scler. Relat. Disord."},{"key":"1047_CR37","doi-asserted-by":"publisher","first-page":"2367","DOI":"10.1002\/mds.28670","volume":"36","author":"JD Schmahmann","year":"2021","unstructured":"Schmahmann, J. D., Pierce, S., MacMore, J. & L\u2019Italien, G. J. Development and validation of a patient\u2010reported outcome measure of ataxia. Mov. Disord. 36, 2367\u20132377 (2021).","journal-title":"Mov. Disord."},{"key":"1047_CR38","doi-asserted-by":"publisher","DOI":"10.1186\/s40900-023-00505-7","volume":"9","author":"T Morel","year":"2023","unstructured":"Morel, T. et al. The value of co-creating a clinical outcome assessment strategy for clinical trial research: process and lessons learnt. Res. Involv. Engagem. 9, 98 (2023).","journal-title":"Res. Involv. Engagem."},{"key":"1047_CR39","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s41687-023-00577-9","volume":"7","author":"T Morel","year":"2023","unstructured":"Morel, T. et al. Development and early qualitative evidence of two novel patient-reported outcome instruments to assess daily functioning in people with early-stage Parkinson\u2019s. J. Patient Rep. Outcomes 7, 40 (2023).","journal-title":"J. Patient Rep. Outcomes"},{"key":"1047_CR40","doi-asserted-by":"publisher","DOI":"10.1186\/s40900-023-00430-9","volume":"9","author":"MY Smith","year":"2023","unstructured":"Smith, M. Y. et al. Patients as research partners in preference studies: learnings from IMI-PREFER. Res. Involv. Engagem. 9, 21 (2023).","journal-title":"Res. Involv. Engagem."},{"key":"1047_CR41","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/1748-5908-7-60","volume":"7","author":"MP Eccles","year":"2012","unstructured":"Eccles, M. P., Grimshaw, J. M., Shekelle, P., Sch\u00fcnemann, H. J. & Woolf, S. Developing clinical practice guidelines: target audiences, identifying topics for guidelines, guideline group composition and functioning and conflicts of interest. Implement. Sci. 7, 60 (2012).","journal-title":"Implement. Sci."},{"key":"1047_CR42","unstructured":"NICE. Patient and Public Involvement Policy. https:\/\/www.nice.org.uk\/about\/nice-communities\/nice-and-the-public\/public-involvement\/public-involvement-programme\/patient-public-involvement-policy (2013)."},{"key":"1047_CR43","unstructured":"EAN. About EAN Guidelines for Neurologists. https:\/\/www.ean.org\/research\/ean-guidelines\/about-ean-guidelines-for-neurologists (2024)."},{"key":"1047_CR44","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.1212\/WNL.54.10.1899","volume":"54","author":"RG Holloway","year":"2000","unstructured":"Holloway, R. G., Benesch, C. & Rush, S. R. Stroke prevention: narrowing the evidence\u2013practice gap. Neurology 54, 1899\u20131906 (2000).","journal-title":"Neurology"},{"key":"1047_CR45","unstructured":"World Stroke Organization. Stroke Advocacy Brochure (World Stroke Organization, 2022)."},{"key":"1047_CR46","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-018-1216-2","volume":"16","author":"P Wicks","year":"2018","unstructured":"Wicks, P. Patient, study thyself. BMC Med. 16, 217 (2018).","journal-title":"BMC Med."},{"key":"1047_CR47","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1038\/nbt.1837","volume":"29","author":"P Wicks","year":"2011","unstructured":"Wicks, P., Vaughan, T. E., Massagli, M. P. & Heywood, J. Accelerated clinical discovery using self-reported patient data collected online and a patient-matching algorithm. Nat. Biotechnol. 29, 411\u2013414 (2011).","journal-title":"Nat. Biotechnol."},{"key":"1047_CR48","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1038\/nbt1009-888","volume":"27","author":"CA Brownstein","year":"2009","unstructured":"Brownstein, C. A., Brownstein, J. S., Williams, D. S., Wicks, P. & Heywood, J. A. The power of social networking in medicine. Nat. Biotechnol. 27, 888\u2013890 (2009).","journal-title":"Nat. Biotechnol."},{"key":"1047_CR49","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/S1474-4422(13)70037-1","volume":"12","author":"Al-Chalabi, A. et al","year":"2013","unstructured":"Al-Chalabi, A. et al Lithium in patients with amyotrophic lateral sclerosis (LiCALS): a phase 3 multicentre, randomised, double-blind, placebo-controlled trial. Lancet Neurol. 12, 339\u2013345 (2013).","journal-title":"Lancet Neurol."},{"key":"1047_CR50","doi-asserted-by":"publisher","first-page":"101019","DOI":"10.1016\/j.eclinm.2021.101019","volume":"38","author":"HE Davis","year":"2021","unstructured":"Davis, H. E. et al. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine 38, 101019 (2021).","journal-title":"EClinicalMedicine"},{"key":"1047_CR51","first-page":"441","volume":"8","author":"S Riggare","year":"2018","unstructured":"Riggare, S. & H\u00e4gglund, M. Precision medicine in Parkinson\u2019s disease \u2014 exploring patient-initiated self-tracking. J. Park. Dis. 8, 441\u2013446 (2018).","journal-title":"J. Park. Dis."},{"key":"1047_CR52","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1002\/mds.28921","volume":"37","author":"I Subramanian","year":"2022","unstructured":"Subramanian, I. et al. Unmet needs of women living with Parkinson\u2019s disease: gaps and controversies. Mov. Disord. 37, 444\u2013455 (2022).","journal-title":"Mov. Disord."},{"key":"1047_CR53","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1007\/s40120-021-00285-w","volume":"10","author":"N Law","year":"2021","unstructured":"Law, N., Davio, K., Blunck, M., Lobban, D. & Seddik, K. The lived experience of myasthenia gravis: a patient-led analysis. Neurol. Ther. 10, 1103\u20131125 (2021).","journal-title":"Neurol. Ther."},{"key":"1047_CR54","doi-asserted-by":"publisher","DOI":"10.1002\/leap.1607","volume":"37","author":"KL Woolley","year":"2024","unstructured":"Woolley, K. L. et al. Patient authorship of medical research publications: an evolution, revolution, and solution? Learn. Publ. 37, e1607 (2024).","journal-title":"Learn. Publ."},{"key":"1047_CR55","unstructured":"Chawla, D. S. Editors give green light to patients co-authoring manuscripts. Nature Index, https:\/\/www.nature.com\/nature-index\/news\/editors-give-green-light-to-patients-co-authoring-manuscripts (2021)."},{"key":"1047_CR56","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2022-071363","volume":"13","author":"M Dahlberg","year":"2023","unstructured":"Dahlberg, M. et al. Objectives and outcomes of patient-driven innovations published in peer-reviewed journals: a qualitative analysis of publications included in a scoping review. BMJ Open. 13, e071363 (2023).","journal-title":"BMJ Open."},{"key":"1047_CR57","unstructured":"Lewis, D. in Personal Health Informatics: Patient Participation in Precision Health (eds Hsueh, P. Y. S., Wetter, T., & Zhu, X.) (Springer, 2022)."},{"key":"1047_CR58","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1111\/hex.13790","volume":"26","author":"C Wannheden","year":"2023","unstructured":"Wannheden, C. et al. A rocky road but worth the drive: a longitudinal qualitative study of patient innovators and researchers cocreating research. Health Expect. 26, 1757\u20131767 (2023).","journal-title":"Health Expect."},{"key":"1047_CR59","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2021-053735","volume":"12","author":"M Reinius","year":"2022","unstructured":"Reinius, M. et al. Patient-driven innovations reported in peer-reviewed journals: a scoping review. BMJ Open. 12, e053735 (2022).","journal-title":"BMJ Open."},{"key":"1047_CR60","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1177\/1932296816665635","volume":"10","author":"D Lewis","year":"2016","unstructured":"Lewis, D., Leibrand, S. & OpenAPS Community. Real-world use of open source artificial pancreas systems. J. Diabetes Sci. Technol. 10, 1411 (2016).","journal-title":"J. Diabetes Sci. Technol."},{"key":"1047_CR61","unstructured":"FDA. CDER Patient-Focused Drug Development. https:\/\/www.fda.gov\/drugs\/development-approval-process-drugs\/cder-patient-focused-drug-development (2024)."},{"key":"1047_CR62","unstructured":"European Medicines Agency. Getting Involved in EMA Activities as a Patient, Consumer or Career. https:\/\/www.ema.europa.eu\/en\/partners-networks\/patients-and-consumers\/getting-involved (2023)."},{"key":"1047_CR63","unstructured":"Regulation (EU) 2021\/2282 of the European Parliament and of the Council of 15 December 2021 on health technology assessment and amending directive 2011\/24\/EU. European Union. https:\/\/eur-lex.europa.eu\/eli\/reg\/2021\/2282\/oj (2021)."},{"key":"1047_CR64","first-page":"1359","volume":"12","author":"MJ Meinders","year":"2022","unstructured":"Meinders, M. J., Donnelly, A. C., Sheehan, M. & Bloem, B. R. Including people with Parkinson\u2019s disease in clinical study design and execution: a call to action. J. Park. Dis. 12, 1359\u20131363 (2022).","journal-title":"J. Park. Dis."},{"key":"1047_CR65","doi-asserted-by":"publisher","DOI":"10.1111\/hex.13914","volume":"27","author":"FE Lithander","year":"2024","unstructured":"Lithander, F. E. et al. Working with public contributors in Parkinson\u2019s research: what were the changes, benefits and learnings? A critical reflection from the researcher and public contributor perspective. Health Expect. 27, e13914 (2024).","journal-title":"Health Expect."},{"key":"1047_CR66","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1038\/s41582-023-00830-1","volume":"19","author":"E Moro","year":"2023","unstructured":"Moro, E. How can we stop digital technologies from worsening existing health inequalities? Nat. Rev. Neurol. 19, 449\u2013450 (2023).","journal-title":"Nat. Rev. Neurol."},{"key":"1047_CR67","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1111\/hex.13087","volume":"23","author":"S Riggare","year":"2020","unstructured":"Riggare, S., Stecher, B. & Stamford, J. Patient advocates respond to \u2018Utilizing Patient Advocates\u2026\u2019 by Feeney et al. Health Expect. 23, 972\u2013973 (2020).","journal-title":"Health Expect."},{"key":"1047_CR68","doi-asserted-by":"publisher","first-page":"2309","DOI":"10.1002\/alz.13644","volume":"20","author":"F Aguzzoli Peres","year":"2024","unstructured":"Aguzzoli Peres, F. et al. Walking the talk for dementia: a unique immersive, embodied, and multi\u2010experiential initiative. Alzheimers Dement. 20, 2309\u20132322 (2024).","journal-title":"Alzheimers Dement."},{"key":"1047_CR69","unstructured":"World Health Organization. Declaration of Alma-Ata (WHO, 1978)."},{"key":"1047_CR70","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1007\/BF01593887","volume":"4","author":"P Fayers","year":"1995","unstructured":"Fayers, P. MRC quality of life studies using a daily diary card\u2014practical lessons learned from cancer trials. Qual. Life Res. 4, 343\u2013352 (1995).","journal-title":"Qual. Life Res."},{"key":"1047_CR71","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/S0140-6736(08)60884-3","volume":"372","author":"MH Merson","year":"2008","unstructured":"Merson, M. H., O\u2019Malley, J., Serwadda, D. & Apisuk, C. The history and challenge of HIV prevention. Lancet 372, 475\u2013488 (2008).","journal-title":"Lancet"},{"key":"1047_CR72","unstructured":"CDC. About the Prevention Research Centers. https:\/\/www.cdc.gov\/prevention-research-centers\/php\/about\/ (2024)."},{"key":"1047_CR73","unstructured":"FDA. Evolution of Patient Engagement at the FDA. https:\/\/www.fda.gov\/patients\/evolution-patient-engagement-fda (2021)."},{"key":"1047_CR74","unstructured":"INVOLVE Coordinating Centre. Starting out: essential information for members of the public getting started in involvement in research (NHS National Institute for Health Research, 2017)."},{"key":"1047_CR75","doi-asserted-by":"crossref","unstructured":"Charlton, J. I. in Nothing About Us Without Us: Disability Oppression and Empowerment (University of California Press, 1998).","DOI":"10.1525\/9780520925441"},{"key":"1047_CR76","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1136\/bmj.326.7402.1279","volume":"326","author":"L Donaldson","year":"2003","unstructured":"Donaldson, L. Expert patients usher in a new era of opportunity for the NHS. BMJ 326, 1279\u20131280 (2003).","journal-title":"BMJ"},{"key":"1047_CR77","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/1477-7525-4-79","volume":"4","author":"U.S. Department of Health and Human Services FDA Center for Drug Evaluation and Research., U.S. Department of Health and Human Services FDA Center for Biologics Evaluation and ResearchU.S. Department of Health and Human Services FDA Center for Devices and Radiological Health.","year":"2006","unstructured":"U.S. Department of Health and Human Services FDA Center for Drug Evaluation and Research., U.S. Department of Health and Human Services FDA Center for Biologics Evaluation and Research & U.S. Department of Health and Human Services FDA Center for Devices and Radiological Health. Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims: draft guidance. Health Qual. Life Outcomes 4, 79 (2006).","journal-title":"Health Qual. Life Outcomes"},{"key":"1047_CR78","unstructured":"European Organisation for Rare Diseases. EURORDIS position paper on research priorities for rare diseases (EURORDIS \u2014 Rare Diseases Europe, 2009)."},{"key":"1047_CR79","unstructured":"Canadian Institutes of Health Research. Strategy for Patient-Oriented Research. http:\/\/www.cihr-irsc.gc.ca\/e\/41204.html (2023)."},{"key":"1047_CR80","unstructured":"NIHR. Improving Inclusion of Under-Served Groups in Clinical Research: Guidance from INCLUDE Project. https:\/\/www.nihr.ac.uk\/improving-inclusion-under-served-groups-clinical-research-guidance-include-project (2024)."},{"key":"1047_CR81","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-020-01641-z","volume":"16","author":"AEM Post","year":"2021","unstructured":"Post, A. E. M. et al. Research priorities for rare neurological diseases: a representative view of patient representatives and healthcare professionals from the European Reference Network for Rare Neurological Diseases. Orphanet J. Rare Dis. 16, 135 (2021).","journal-title":"Orphanet J. Rare Dis."},{"key":"1047_CR82","unstructured":"European Medicines Agency. EMA Regulatory Science to 2025 (EMA, 2018)."},{"key":"1047_CR83","unstructured":"Karagianni, E. Call for EoI for the IMI pool of patient experts. Innovative Medicines Initiative. https:\/\/www.ihi.europa.eu\/sites\/default\/files\/uploads\/documents\/get-involved\/patients\/PatientExpertWebinar.pdf (2019)."},{"key":"1047_CR84","unstructured":"European Commission. Horizon 2020. https:\/\/research-and-innovation.ec.europa.eu\/funding\/funding-opportunities\/funding-programmes-and-open-calls\/horizon-2020_en (2024)."},{"key":"1047_CR85","unstructured":"FDA. Plan for Issuance of Patient\u2010Focused Drug Development Guidance (FDA, 2017)."},{"key":"1047_CR86","unstructured":"FDA. FDA patient-focused drug development guidance series for enhancing the incorporation of the patient\u2019s voice in medical product development and regulatory decision making. https:\/\/www.fda.gov\/drugs\/development-approval-process-drugs\/fda-patient-focused-drug-development-guidance-series-enhancing-incorporation-patients-voice-medical (2023)."},{"key":"1047_CR87","unstructured":"European Medicines Agency & FDA. Terms of Reference for the EMA\/FDA Cluster on Patient Engagement (EMA & FDA, 2016)."},{"key":"1047_CR88","unstructured":"World Health Organization. Optimizing Brain Health Across the Life Course: WHO Position Paper (WHO, 2022)."},{"key":"1047_CR89","first-page":"66","volume":"13","author":"F Ruiz Gonzalez","year":"2023","unstructured":"Ruiz Gonzalez, F. et al. Parkinson disease in women: how does sex affect motor and non-motor symptoms? J. Park. Dis. 13, 66 (2023).","journal-title":"J. Park. Dis."},{"key":"1047_CR90","first-page":"373","volume":"13","author":"S Mathur","year":"2023","unstructured":"Mathur, S., Kristi Lamonica, K., Hill, K. & Matthews, H. Comprehensive survey data set of women with Parkisnon\u2019s by women with Parkinson\u2019s. J. Park. Dis. 13, 373 (2023).","journal-title":"J. Park. Dis."}],"container-title":["Nature Reviews Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41582-024-01047-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41582-024-01047-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41582-024-01047-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T13:03:01Z","timestamp":1741093381000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41582-024-01047-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,7]]},"references-count":90,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["1047"],"URL":"https:\/\/doi.org\/10.1038\/s41582-024-01047-6","relation":{},"ISSN":["1759-4758","1759-4766"],"issn-type":[{"value":"1759-4758","type":"print"},{"value":"1759-4766","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,7]]},"assertion":[{"value":"26 November 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"M.T.F. is the co-founder of the Women\u2019s Brain Project. In the past 2 years she has received consulting and speaking fees from Roche, Angelini Pharma and Prodeco Pharma unrelated to this project. She is currently the Clinical Development Lead of Syntropic Medical. M.U. has received honoraria for consulting services from Alexion, Janssen, Merck, UCB\u00a0Pharma and UCB S.A., and speaking fees from Alexion and UCB\u00a0S.A.. She also provided consulting services to Argenx. Travel expenses for congresses were paid by Alexion, UCB\u00a0Pharma, UCB S.A. and Argenx. R.F. is the co-founder and chief executive officer of My Moves Matter. E.M. has received restricted research grant support from Abbott and France Parkinson. She has also received honoraria from Medtronic for consultation services. I.L. declares advisory boards and honoraria for talks from Roche, NovoNordisk, Eli Lilly and Boehringer.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}